GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states
about
Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfateMouse models of Down syndrome as a tool to unravel the causes of mental disabilitiesGastrodiae Rhizoma (tiān má): a review of biological activity and antidepressant mechanismsFunctional regulation of GABAA receptors in nervous system pathologiesStress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsyActivin in the brain modulates anxiety-related behavior and adult neurogenesisGABAA receptor-acting neurosteroids: a role in the development and regulation of the stress response50 years of hurdles and hope in anxiolytic drug discoveryThe biochemical anatomy of cortical inhibitory synapsesGABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism.GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.The GABAergic deficit hypothesis of major depressive disorder.Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.Removal of GABA(A) receptor γ2 subunits from parvalbumin neurons causes wide-ranging behavioral alterations.Varied access to intravenous methamphetamine self-administration differentially alters adult hippocampal neurogenesis.gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice.Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic interneuron network.GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factorsDisinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state.Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats.Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice.Biological substrates underpinning diagnosis of major depression.Sex differences in diazepam effects and parvalbumin-positive GABA neurons in trait anxiety Long Evans rats.Neurogenic potential of the vestibular nuclei and behavioural recovery time course in the adult cat are governed by the nature of the vestibular damageMethyl donor-deficient diet during development can affect fear and anxiety in adulthood in C57BL/6J mice.Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndromeWithdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrusWhy are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings.α2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders.GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice.Antidepressant-like properties of α2-containing GABA(A) receptors.Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABAA receptor-deficient mice.Extended access methamphetamine decreases immature neurons in the hippocampus which results from loss and altered development of neural progenitors without altered dynamics of the S-phase of the cell cyclePostnatal loss of hap1 reduces hippocampal neurogenesis and causes adult depressive-like behavior in mice.Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes.Activity-regulated gene expression in immature neurons in the dentate gyrus following re-exposure to a cocaine-paired environment.Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights.Neuronal overexpression of Glo1 or amygdalar microinjection of methylglyoxal is sufficient to regulate anxiety-like behavior in mice.Fast synaptic inhibition in spinal sensory processing and pain control.
P2860
Q24598684-B6CD667E-B59B-4484-A714-DEC77899E50EQ26863005-A1F8EE63-0047-4876-90E5-479C455AB83CQ27006845-2A4B6F94-A62E-42D0-A16D-1D0F0EBE9126Q27013597-5DB41A08-6058-44EF-BA53-A4EFCF89C54FQ27013911-EF4C9990-622B-452C-A19D-72C508EA2762Q27301518-9839F532-4240-4BC0-A58B-F8C30F7ACF05Q28241963-3C49D4E0-5C30-4DC5-B6E4-E0835717669BQ28297569-993EDADA-E408-4122-A528-E7946177B2D7Q28480914-34EE169E-84CB-4C5E-8224-5E19F9AC6074Q30363617-105D4443-AB5E-44AA-8A5A-68317F935B17Q30421260-897F6727-B100-436A-BC96-EEC1993CD059Q30464954-F2271171-B287-402D-ADCC-A5B5E42137A4Q30466591-C3D44FBD-7981-4332-A555-E197384CB1A9Q30474166-6AF29E47-14AD-4789-9D12-B2F45C0656CDQ30484730-E9C6D7B6-8067-4ABE-8E84-8DAD2438EF39Q30496339-F8ECD403-9FDF-4E66-AA02-5126AF8A5DE9Q30497475-B4738781-6618-461E-9495-1E3796255F26Q30497843-6BCB9AC5-9290-45CE-A4E1-77976F776887Q30612805-3769F5CD-C88F-44A5-8241-5A08D1E25A81Q30848010-30EA565E-261D-4113-A832-7D9D30A63837Q33334413-66F29955-DB80-436C-B5FA-3069CFD100DFQ33700449-4A31867D-4A52-42A9-B19C-2783A30874E5Q33820463-F399BFD5-31BB-46D1-B618-FDC95E7D3ACDQ33954793-35C8BB17-81FD-4230-BC10-EEE98BD4B7B0Q33996755-689402AE-0D17-42D7-9C6F-DB387ACCCA26Q34075669-C203F960-B4B9-40B9-926E-FEDF886C579DQ34133976-ABE651F3-9A44-4D86-AAC5-CF532ABA64D6Q34158869-820ECBB8-8476-46BF-9FE3-1246BD215CB0Q34216839-ECE6D0AE-9945-4AF7-84FC-BCE116F65EA4Q34295813-BA6FC2E4-80C4-4D39-93F2-2C165438642EQ34448259-A4983481-7C64-4545-8AB2-2804A41284E2Q34504773-2D6A7E0C-1E0A-4CE9-8FFA-1531211DAAB4Q34615783-D4B57EA4-5364-460F-A515-BD7774076662Q35242144-F910BA82-A9DF-4684-8A1E-4F9A650BBCA5Q35432034-853D50BD-306F-4360-80CD-D81999DA14D0Q35924378-6AFAA998-615B-44AE-AADB-10B54EE26D8CQ36064105-0DB1E58F-7F60-4CDC-8925-AF8B87401E8CQ36407601-249185A7-27A6-4C93-99D8-22EBAFCF1C0BQ36505607-FA5EDB1D-5074-4CE9-A081-190C7A31BCB2Q36661675-ADD5A0C2-911A-4E06-BF0C-0431F6B0F753
P2860
GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
GABAergic control of adult hip ...... anxiety and depression states
@ast
GABAergic control of adult hip ...... anxiety and depression states
@en
type
label
GABAergic control of adult hip ...... anxiety and depression states
@ast
GABAergic control of adult hip ...... anxiety and depression states
@en
prefLabel
GABAergic control of adult hip ...... anxiety and depression states
@ast
GABAergic control of adult hip ...... anxiety and depression states
@en
P2093
P2860
P1476
GABAergic control of adult hip ...... anxiety and depression states
@en
P2093
Claude Schweizer
Florence Crestani
Hanns Mohler
John C Earnheart
Takuji Iwasato
P2860
P304
P356
10.1523/JNEUROSCI.3609-06.2007
P407
P577
2007-04-01T00:00:00Z